The global ophthalmoscopes market accounted to US$ 216.79 in 2018 and is expected to grow at a CAGR of 4.6% during the forecast period 2019 - 2027, to account to US$ 322.13 Mn by 2027.
The market for ophthalmoscopes is expected to grow significantly due to factor as rising prevalence of eye diseases in developing and developed nations, significantly growing elderly population and increasing prevalence of glaucoma in individuals are likely to drive the growth of the market in the forecasted period. However, the challenges associated with retinal examination may show some impact to the growth of the market.
The players in the market are adopting various inorganic and organic developments for the individual growth and thus the growth of the market is highly dependent on them. The vital players in the ophthalmoscopes treatment devices market focus on various growth strategies to enroot their presence and garner major market share across the globe.
Some of the notable players in the global ophthalmoscopes market includes Welch Allyn, Heine USA Ltd., Iridex., Carl Zeiss Meditec AG, American Diagnostic Corporation, Honsun, Halma plc, Lumenis and Guangzhou Bisen Medical Co., Limited among others. The major market players within the recent years, have been observed to invest a substantial amount towards the development of new products. This implies a bright picture on the type of strategies majorly incorporated by the market players to sustain their positions as well as to generate increased growth revenue in the ophthalmoscopes market. The global leaders in the market have been majorly adopting product launches and product up-gradation as one of the key strategy to improve its product lines in order to build up a customer centric benefits to its end users and enhance its geographic diversification.
Global ophthalmoscopes market, based on type, application, and end user. The market based on the type segment is classified as direct ophthalmoscopes and indirect ophthalmoscopes. Based on the application, the market is classified as glaucoma, diabetes eye diseases, retinal diseases and others. Similarly, on the basis of the end user the market is classified is hospitals, eye clinics and ambulatory surgical clinics. Based on the application, glaucoma is the largest contributor for the growth of the ophthalmoscopes market. Likewise, the direct ophthalmoscopes is the largest contributor by type for the market.
The global leaders are expanding their activities across the world and are developing various innovative techniques to diagnose the eye conditions. For instance, Carl Zeiss Meditec AG has launched total keratometry for the IOLMaster 700 that offers opportunities to cataract surgeons for the replacement of assumptions about the posterior corneal surface with precise measurements, which will enhance the their results. Additionally, the company has also announced receiving approval from FDA for its Advanced Nerve and Glaucoma Imaging (A N G I) Network. The major goal of the company is to enhance the global collaborations so as to elevate the latest research in Glaucoma and optic nerve diseases. Thus, the considering these developments the for the ophthalmology industry the players operating for the ophthalmoscopes are likely to improve their performance and provide enormous benefits to their customers and end users.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.